Difference between revisions of "Microbiology"
(→What is already known) |
|||
| Line 2: | Line 2: | ||
=What is already known= | =What is already known= | ||
| + | * Laboratory surge capacity is a critical success factor in pandemic preparedness | ||
| + | * ECDC has surveyed laboratory capacity in the EU (EULabCap) and reported in 2016. <Ref Name=“EULABCAP”> European Centre for Disease Prevention and Control. European Centre for Disease Prevention and Control. [https://www.ecdc.europa.eu/sites/default/files/documents/2016_EULabCap_EUreport_web_300418_final.pdf EU Laboratory Capability Monitoring System (EULabCap)] – Report on 2016 survey of EU/EEA country capabilities and capacities. Stockholm: ECDC; 2018</ref> | ||
| + | ** | ||
| + | ** Outbreak Assistance Laboratories in the Netherlands were found in 2009 to have sufficient capacity to process xxx samples per month of BSL3 respiratory pathogens, in addition to the routine diagnostics.<Ref name=“LvAsten”> Asten, L. van, Lubben, M. van der, Wijngaard, C. van den, Pelt, W. van, Verheij, R., Jacobi, A., Overduin, P., Meijer, A., Luijt, D., Claas, E., Hermans, M., Melchers, W., Rossen, J., Schuurman, R., Woffs, P., Boucher, C., Schirm, J., Kroes, L., Leenders, S., Galama, J., Peeters, M., Loon, A. van, Stobberingh, E., Schutten, M., Koopmans, M. Strengthening the diagnostic capacity to detect Bio Safety Level 3 organisms in unusual respiratory viral outbreaks. Journal of Clinical Virology: 2009, 45(3), 185-190</ref> | ||
| + | |||
| + | ==Observation== | ||
| + | * Large differences exist between EU countries in numbers of Corona tests performed per capita (ref) | ||
| + | * | ||
=Topic 1= | =Topic 1= | ||
Revision as of 21:57, 23 March 2020
This page collects observations, interpretations, and consequences for action about Microbiology in general of SARS-CoV2. Please observe the structure of the page, when you add your content. Please use references where possible. Remember to find the relevant page. For example, if your observation is about Sources, please use that page, instead of posting your content here. If you have specific microbiological topics that warrant a separate page, please create one.
Contents
What is already known
- Laboratory surge capacity is a critical success factor in pandemic preparedness
- ECDC has surveyed laboratory capacity in the EU (EULabCap) and reported in 2016. [1]
- Outbreak Assistance Laboratories in the Netherlands were found in 2009 to have sufficient capacity to process xxx samples per month of BSL3 respiratory pathogens, in addition to the routine diagnostics.[2]
Observation
- Large differences exist between EU countries in numbers of Corona tests performed per capita (ref)
Topic 1
Observations
Analysis and interpretation
Consequences for action
References
- ↑ European Centre for Disease Prevention and Control. European Centre for Disease Prevention and Control. EU Laboratory Capability Monitoring System (EULabCap) – Report on 2016 survey of EU/EEA country capabilities and capacities. Stockholm: ECDC; 2018
- ↑ Asten, L. van, Lubben, M. van der, Wijngaard, C. van den, Pelt, W. van, Verheij, R., Jacobi, A., Overduin, P., Meijer, A., Luijt, D., Claas, E., Hermans, M., Melchers, W., Rossen, J., Schuurman, R., Woffs, P., Boucher, C., Schirm, J., Kroes, L., Leenders, S., Galama, J., Peeters, M., Loon, A. van, Stobberingh, E., Schutten, M., Koopmans, M. Strengthening the diagnostic capacity to detect Bio Safety Level 3 organisms in unusual respiratory viral outbreaks. Journal of Clinical Virology: 2009, 45(3), 185-190
